Resolvin D1 reduces cancer growth stimulating a protective neutrophil-dependent recruitment of anti-tumor monocytes

xloma.fota13 shared this article with you from Inoreader Resolvin D1 reduces cancer growth stimulating a protective neutrophil-dependent recruitment of anti-tumor monocytes Via Journal of Experimental & Clinical Cancer Research - Latest Articles Innovative therapies to target tumor-associated neutrophils (PMN) are of clinical interest, since these cells are centrally involved in cancer inflammation and tumor progression. Resolvin D1 (RvD1) is a lipid ... View on the web Inoreader. Take back control of your news feed. Follow us on Twitter and Facebook.